Roche took the opportunity to reassure investors and analysts as it
outlined its plans to deal with the impending threat to Avastin and
Herceptin. Roche's new indications for cancer treatments suggest
that its oncology portfolio...
A study that has uncovered core functional differences between a
new oestrogen receptor could form the basis of novel and
potentially more effective treatments of breast cancer as
researchers sought to utilise this therapeutic target.
A new class of drug that targets breast cancer by blocking
production of oestrogen and reducing serious side effects for many
more, could eventually become the gold-standard for cancer
treatment.
Genentech has entered into a collaboration with biopharmaceutical
firm Immunogen to develop a commercial manufacturing process for
its anticancer drug trastuzumab (Herceptin) using its
tumour-activated prodrug (TAP) technology.
ExonHit and bioMirieux have announced that scientific data
generated in the detection of breast cancer could well lead to the
development of novel diagnostic tests that will enable the early
detection of breast cancer from blood.
Two days after it filed for approval of Hecerptin for the treatment
of early-stage HER2-positive breast cancer in the US through its
majority-own biotechnology firm Genentech, Swiss drugmaker Roche
has followed suit in the EU, looking...
The breast cancer therapeutics market is expected to show sustained
growth and opportunity for new market participants as greater
efficacy and reduced toxicity of innovative breast cancer therapies
increase their uptake.
According to a new report, more than 400 new medicines are in
development to treat diseases that affect US women, including 62
medicines now in testing to treat breast cancer.
Bionovo has announced data identifying a novel class of Oestrogen
receptor-subtype modulators, which provides solid evidence of a
potentially safer alternative treatment to hormone therapy that
treats hot flashes and night sweats.
Scientists have discovered the genetic pathway responsible for
breast cancer growth, which details how the female hormone
oestrogen causes growth of breast cancer cells. In practical terms,
efforts can now be focused on developing...
Scientists have hailed an experimental drug, which fights tumours
linked to two faulty genes in breast cancer, as a breakthrough in
the fight against cancer. Animal tests have shown the drug prevents
the growth of tumours so effectively...
Roche has started the roll-out its colorectal cancer treatment
Avastin (bevacizumab) - the first drug to reach the market that
works by inhibiting blood vessel formation in tumours - in Europe.
A widely used drug to treat breast cancer has been significantly
improved by the use of a new technology that binds it to albumin, a
common constituent of human blood.
Pharmaceutical scientists at Cardiff University, UK, have developed
a new method of delivering drugs for treating breast cancer that
promises to be more effective than current treatments
A new report into pharmaceutical R&D worldwide identifies a
changing trend in increasing R&D focus of drugs for breast
cancer treatment compared with those for prostate cancer. This may
account for prostate cancer becoming...
In the first study of its kind, researchers have identified the
genes in non-cancerous supporting cells that can encourage the
growth of breast cancer cells. The findings suggest aiming
chemotherapy at both normal and cancer cells...